These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 541377)

  • 21. Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid.
    Wang S; Berge GE; Hoem NO; Sund RB
    Res Vet Sci; 2001 Aug; 71(1):27-32. PubMed ID: 11666144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of ascorbic acid in human urine by high-performance liquid chromatography coupled with fluorimetry after post-column derivatization with benzamidine.
    Seki T; Yamaguchi Y; Noguchi K; Yanagihara Y
    J Chromatogr; 1987 Jan; 385():287-91. PubMed ID: 3558584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of furosemide in plasma and urine using monolithic silica rod liquid chromatography.
    Wenk M; Haegeli L; Brunner H; Krähenbühl S
    J Pharm Biomed Anal; 2006 Jun; 41(4):1367-70. PubMed ID: 16569489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral bioavailability, urinary excretion and organ distribution of melamine in Sprague-Dawley rats by high-performance liquid chromatography with tandem mass spectrometry.
    Wu YT; Huang CM; Lin CC; Ho WA; Lin LC; Chiu TF; Tarng DC; Lin CH; Tsai TH
    J Agric Food Chem; 2010 Jan; 58(1):108-11. PubMed ID: 20014856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ascorbic acid abuse: effects on long term ingestion of excessive amounts on blood levels and urinary excretion.
    Schrauzer GN; Rhead WJ
    Int J Vitam Nutr Res; 1973; 43(2):201-11. PubMed ID: 4716569
    [No Abstract]   [Full Text] [Related]  

  • 26. High-performance liquid chromatographic determination of cilastatin and its major metabolite N-acetylcilastatin in rat plasma, urine and bile.
    Chen IW; Hsieh JY; Lin JH; Duggan DE
    J Chromatogr; 1990 Dec; 534():119-26. PubMed ID: 2094698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary intake and plasma concentrations of vitamin E, vitamin C, and beta carotene in patients with coronary artery disease.
    Mandel CH; Mosca L; Maimon E; Sievers J; Tsai A; Rock CL
    J Am Diet Assoc; 1997 Jun; 97(6):655-7. PubMed ID: 9183328
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
    Ambruso DR; Mahony BS; Githens JH; Rhoades ED
    Am J Pediatr Hematol Oncol; 1982; 4(2):115-23. PubMed ID: 7114394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of vitamin C supplementation on plasma concentration and urinary excretion of vitamin C in cattle.
    Padilla L; Matsui T; Ikeda S; Kitagawa M; Yano H
    J Anim Sci; 2007 Dec; 85(12):3367-70. PubMed ID: 17785598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ascorbic acid elimination in humans after intravenous administration.
    Yung S; Mayersohn M; Robinson JB
    J Pharm Sci; 1978 Oct; 67(10):1491-2. PubMed ID: 702316
    [No Abstract]   [Full Text] [Related]  

  • 31. Vitamin C activity of dehydroascorbic acid in humans--association between changes in the blood vitamin C concentration or urinary excretion after oral loading.
    Tsujimura M; Higasa S; Nakayama K; Yanagisawa Y; Iwamoto S; Kagawa Y
    J Nutr Sci Vitaminol (Tokyo); 2008 Aug; 54(4):315-20. PubMed ID: 18797154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ascorbic acid on calcium elimination in humans.
    Tsao CS; Miyashita K; Leung PY
    J Nutr Sci Vitaminol (Tokyo); 1986 Aug; 32(4):437-46. PubMed ID: 3806257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of intravenous ascorbic acid on urinary 17-hydroxysteroid excretion at an early stage of cerebral stroke].
    Nadgrodkiewicz K
    Neurol Neurochir Pol; 1996; 30(1):49-56. PubMed ID: 8657350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of ascorbic acid-2-sulfate by high-performance liquid chromatography with electrochemical detection.
    Tsao CS; Young M; Rose SM
    J Chromatogr; 1984 Jun; 308():306-9. PubMed ID: 6746823
    [No Abstract]   [Full Text] [Related]  

  • 35. The excretion of large vitamin C loads in young and elderly subjects: an ascorbic acid tolerance test.
    Neale RJ; Lim H; Turner J; Freeman C; Kemm JR
    Age Ageing; 1988 Jan; 17(1):35-41. PubMed ID: 3364309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of rebound effect with ascorbic acid.
    Tsao CS; Salimi SL
    Med Hypotheses; 1984 Mar; 13(3):303-10. PubMed ID: 6717321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascorbic acid utilization by women: response of serum level and night urinary excretion to increasing levels of intake.
    POTGIETER M; MORSE EH; WALKER GR
    J Nutr; 1955 Feb; 55(2):217-24. PubMed ID: 14354459
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversed-phase high-performance liquid chromatographic determination of salbutamol in rabbit plasma.
    Kurosawa N; Morishima S; Owada E; Ito K
    J Chromatogr; 1984 Feb; 305(2):485-8. PubMed ID: 6707175
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of adrenocorticotropic hormone and cortisone acetate on the urinary and blood levels of ascorbic acid in man.
    BECK JC; BROWNE JS; MACKENZIE KR
    J Clin Endocrinol Metab; 1954 Sep; 14(9):1006-22. PubMed ID: 13192169
    [No Abstract]   [Full Text] [Related]  

  • 40. Noneffect of oral urinary copper ascorbic acid on reduction glucose test.
    Nahata MC; McLeod DC
    Diabetes Care; 1978; 1(1):34-5. PubMed ID: 554783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.